BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29803939)

  • 1. The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis.
    Gordts PLSM; Esko JD
    Matrix Biol; 2018 Oct; 71-72():262-282. PubMed ID: 29803939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate proteoglycans.
    Sarrazin S; Lamanna WC; Esko JD
    Cold Spring Harb Perspect Biol; 2011 Jul; 3(7):. PubMed ID: 21690215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation.
    Pessentheiner AR; Ducasa GM; Gordts PLSM
    Front Immunol; 2020; 11():769. PubMed ID: 32508807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial subversion of heparan sulfate proteoglycans.
    Chen Y; Götte M; Liu J; Park PW
    Mol Cells; 2008 Nov; 26(5):415-26. PubMed ID: 18799929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans.
    Tsiantoulas D; Eslami M; Obermayer G; Clement M; Smeets D; Mayer FJ; Kiss MG; Enders L; Weißer J; Göderle L; Lambert J; Frommlet F; Mueller A; Hendrikx T; Ozsvar-Kozma M; Porsch F; Willen L; Afonyushkin T; Murphy JE; Fogelstrand P; Donzé O; Pasterkamp G; Hoke M; Kubicek S; Jørgensen HF; Danchin N; Simon T; Scharnagl H; März W; Borén J; Hess H; Mallat Z; Schneider P; Binder CJ
    Nature; 2021 Sep; 597(7874):92-96. PubMed ID: 34433968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis.
    Rao G; Ding HG; Huang W; Le D; Maxhimer JB; Oosterhof A; van Kuppevelt T; Lum H; Lewis EJ; Reddy V; Prinz RA; Xu X
    Diabetologia; 2011 Jun; 54(6):1527-38. PubMed ID: 21424539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential roles of vessel wall heparan sulfate proteoglycans in atherosclerosis.
    Madonna R; De Caterina R
    Vascul Pharmacol; 2014 Feb; 60(2):49-51. PubMed ID: 24333941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific structural features of syndecans and heparan sulfate chains are needed for cell signaling.
    Lopes CC; Dietrich CP; Nader HB
    Braz J Med Biol Res; 2006 Feb; 39(2):157-67. PubMed ID: 16470302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate proteoglycans: structure, protein interactions and cell signaling.
    Dreyfuss JL; Regatieri CV; Jarrouge TR; Cavalheiro RP; Sampaio LO; Nader HB
    An Acad Bras Cienc; 2009 Sep; 81(3):409-29. PubMed ID: 19722012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functions of cell surface heparan sulfate proteoglycans.
    Bernfield M; Götte M; Park PW; Reizes O; Fitzgerald ML; Lincecum J; Zako M
    Annu Rev Biochem; 1999; 68():729-77. PubMed ID: 10872465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers.
    Hull EE; Montgomery MR; Leyva KJ
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions.
    Tumova S; Woods A; Couchman JR
    Int J Biochem Cell Biol; 2000 Mar; 32(3):269-88. PubMed ID: 10716625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteoglycan mediated lipoprotein retention: a mechanism of diabetic atherosclerosis.
    Tannock LR; King VL
    Rev Endocr Metab Disord; 2008 Dec; 9(4):289-300. PubMed ID: 18584330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
    Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
    J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting heparan sulfate proteoglycans in breast cancer treatment.
    Koo CY; Sen YP; Bay BH; Yip GW
    Recent Pat Anticancer Drug Discov; 2008 Nov; 3(3):151-8. PubMed ID: 18991783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate proteoglycans at a glance.
    Kirkpatrick CA; Selleck SB
    J Cell Sci; 2007 Jun; 120(Pt 11):1829-32. PubMed ID: 17515480
    [No Abstract]   [Full Text] [Related]  

  • 17. Extracellular distribution of diffusible growth factors controlled by heparan sulfate proteoglycans during mammalian embryogenesis.
    Matsuo I; Kimura-Yoshida C
    Philos Trans R Soc Lond B Biol Sci; 2014 Dec; 369(1657):. PubMed ID: 25349453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins.
    Jalkanen M; Rapraeger A; Bernfield M
    J Cell Biol; 1988 Mar; 106(3):953-62. PubMed ID: 2964452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of abdominal aortic aneurysms: possible role of differential production of proteoglycans by smooth muscle cells.
    Melrose J; Whitelock J; Xu Q; Ghosh P
    J Vasc Surg; 1998 Oct; 28(4):676-86. PubMed ID: 9786264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan Sulfate Proteoglycans in Human Colorectal Cancer.
    Vicente CM; da Silva DA; Sartorio PV; Silva TD; Saad SS; Nader HB; Forones NM; Toma L
    Anal Cell Pathol (Amst); 2018; 2018():8389595. PubMed ID: 30027065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.